Literature DB >> 2119143

Increased tau messenger RNA in Alzheimer's disease hippocampus.

A J Barton1, P J Harrison, A Najlerahim, J Heffernan, B McDonald, J R Robinson, D C Davies, W J Harrison, P Mitra, J A Hardy.   

Abstract

The microtubule-associated protein tau is present in the pathologic hallmarks of Alzheimer's disease and its production and deposition have been implicated in the pathogenesis of the disease. We detected tau mRNA using in situ hybridization histochemistry in the hippocampus, visual cortex, and cerebellum, and compared its level in Alzheimer's disease with controls. The amount of tau mRNA also was determined as a ratio of total polyadenylated mRNA in each area. A significant and gene-specific increase in tau mRNA hybridization was found in hippocampal fields CA4 and CA3, with a similar trend in the dentate gyrus. In contrast, no change was found in the visual cortex or cerebellum in Alzheimer's disease. Increased hippocampal expression of tau mRNA also was present in cases of non-Alzheimer's dementia. Enhanced tau mRNA may be a marker of attempted plasticity involving the cytoskeleton in neuronal populations affected by various neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2119143      PMCID: PMC1877517     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  An immunocytochemical and biochemical study of the microtubule-associated protein Tau during post-lesion afferent reorganization in the hippocampus of adult rats.

Authors:  J Busciglio; A Ferreira; O Steward; A Cáceres
Journal:  Brain Res       Date:  1987-09-01       Impact factor: 3.252

2.  An immunocytochemical analysis of the ontogeny of the microtubule-associated proteins MAP-2 and Tau in the nervous system of the rat.

Authors:  A Ferreira; J Busciglio; A Cáceres
Journal:  Brain Res       Date:  1987-07       Impact factor: 3.252

Review 3.  Synaptic plasticity and functional stabilization in the hippocampal formation: possible role in Alzheimer's disease.

Authors:  C W Cotman; K J Anderson
Journal:  Adv Neurol       Date:  1988

4.  Tau in situ hybridization in normal and Alzheimer brain: localization in the somatodendritic compartment.

Authors:  K S Kosik; J E Crandall; E J Mufson; R L Neve
Journal:  Ann Neurol       Date:  1989-09       Impact factor: 10.422

5.  Characterization of two pathological tau protein, variants in Alzheimer brain cortices.

Authors:  S Flament; A Delacourte; B Hémon; A Défossez
Journal:  J Neurol Sci       Date:  1989-09       Impact factor: 3.181

6.  Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2.

Authors:  R L Neve; P Harris; K S Kosik; D M Kurnit; T A Donlon
Journal:  Brain Res       Date:  1986-12       Impact factor: 3.252

7.  Neurofilament and tubulin expression recapitulates the developmental program during axonal regeneration: induction of a specific beta-tubulin isotype.

Authors:  P N Hoffman; D W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

8.  Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau.

Authors:  M Goedert; C M Wischik; R A Crowther; J E Walker; A Klug
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

9.  Dendritic extent in human CA2-3 hippocampal pyramidal neurons in normal aging and senile dementia.

Authors:  D G Flood; M Guarnaccia; P D Coleman
Journal:  Brain Res       Date:  1987-04-14       Impact factor: 3.252

10.  Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease.

Authors:  N W Kowall; K S Kosik
Journal:  Ann Neurol       Date:  1987-11       Impact factor: 10.422

View more
  9 in total

1.  Immunohistochemical Analysis of Activin Receptor-Like Kinase 1 (ACVRL1/ALK1) Expression in the Rat and Human Hippocampus: Decline in CA3 During Progression of Alzheimer's Disease.

Authors:  Stephanie L Adams; Laurent Benayoun; Kathy Tilton; Tiffany J Mellott; Sudha Seshadri; Jan Krzysztof Blusztajn; Ivana Delalle
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 2.  Adrenal steroids and plasticity of hippocampal neurons: toward an understanding of underlying cellular and molecular mechanisms.

Authors:  B S McEwen; H Cameron; H M Chao; E Gould; A M Magarinos; Y Watanabe; C S Woolley
Journal:  Cell Mol Neurobiol       Date:  1993-08       Impact factor: 5.046

3.  Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51.

Authors:  M Novak; R Jakes; P C Edwards; C Milstein; C M Wischik
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

Review 4.  Environmental factors in the development and progression of late-onset Alzheimer's disease.

Authors:  Moses N Wainaina; Zhichun Chen; Chunjiu Zhong
Journal:  Neurosci Bull       Date:  2014-03-24       Impact factor: 5.203

5.  Autophagy Induction and Accumulation of Phosphorylated Tau in the Hippocampus and Prefrontal Cortex of Adult C57BL/6 Mice Subjected to Adolescent Fluoxetine Treatment.

Authors:  Jorge A Sierra-Fonseca; Minerva Rodriguez; Anapaula Themann; Omar Lira; Francisco J Flores-Ramirez; Javier Vargas-Medrano; Bharathi S Gadad; Sergio D Iñiguez
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 6.  The role of extracellular Tau in the spreading of neurofibrillary pathology.

Authors:  Miguel Medina; Jesús Avila
Journal:  Front Cell Neurosci       Date:  2014-04-23       Impact factor: 5.505

Review 7.  New Features about Tau Function and Dysfunction.

Authors:  Miguel Medina; Félix Hernández; Jesús Avila
Journal:  Biomolecules       Date:  2016-04-19

8.  Extrasynaptic NMDA receptor-induced tau overexpression mediates neuronal death through suppressing survival signaling ERK phosphorylation.

Authors:  Xu-Ying Sun; Qing-Zhang Tuo; Zhen-Yu Liuyang; Ao-Ji Xie; Xiao-Long Feng; Xiong Yan; Mei Qiu; Shen Li; Xiu-Lian Wang; Fu-Yuan Cao; Xiao-Chuan Wang; Jian-Zhi Wang; Rong Liu
Journal:  Cell Death Dis       Date:  2016-11-03       Impact factor: 8.469

9.  TDP-43 suppresses tau expression via promoting its mRNA instability.

Authors:  Jianlan Gu; Feng Wu; Wen Xu; Jianhua Shi; Wen Hu; Nana Jin; Wei Qian; Xinglong Wang; Khalid Iqbal; Cheng-Xin Gong; Fei Liu
Journal:  Nucleic Acids Res       Date:  2017-06-02       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.